194 related articles for article (PubMed ID: 14966910)
1. Expression of HIF-2alpha/EPAS1 in hepatocellular carcinoma.
Bangoura G; Yang LY; Huang GW; Wang W
World J Gastroenterol; 2004 Feb; 10(4):525-30. PubMed ID: 14966910
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of HIF-2alpha/EPAS1 expression in hepatocellular carcinoma.
Bangoura G; Liu ZS; Qian Q; Jiang CQ; Yang GF; Jing S
World J Gastroenterol; 2007 Jun; 13(23):3176-82. PubMed ID: 17589895
[TBL] [Abstract][Full Text] [Related]
3. The correlation of expression levels of HIF-1α and HIF-2α in hepatocellular carcinoma with capsular invasion, portal vein tumor thrombi and patients' clinical outcome.
Yang SL; Liu LP; Jiang JX; Xiong ZF; He QJ; Wu C
Jpn J Clin Oncol; 2014 Feb; 44(2):159-67. PubMed ID: 24374892
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-induced, perinecrotic expression of endothelial Per-ARNT-Sim domain protein-1/hypoxia-inducible factor-2alpha correlates with tumor progression, vascularization, and focal macrophage infiltration in bladder cancer.
Onita T; Ji PG; Xuan JW; Sakai H; Kanetake H; Maxwell PH; Fong GH; Gabril MY; Moussa M; Chin JL
Clin Cancer Res; 2002 Feb; 8(2):471-80. PubMed ID: 11839666
[TBL] [Abstract][Full Text] [Related]
5. Positive expression of HIF-2alpha/EPAS1 in invasive bladder cancer.
Xia G; Kageyama Y; Hayashi T; Hyochi N; Kawakami S; Kihara K
Urology; 2002 May; 59(5):774-8. PubMed ID: 11992927
[TBL] [Abstract][Full Text] [Related]
6. Effect of endothelial PAS domain protein 1 and hypoxia inducible factor 1alpha on vascular endothelial growth factor expression in human pancreatic carcinoma.
Zhu DM; Li DC; Zhang ZX; Zhang XY
Chin Med J (Engl); 2008 Nov; 121(22):2258-64. PubMed ID: 19080330
[TBL] [Abstract][Full Text] [Related]
7. [Effect of HIF-2α on regulating CDCP1 to promote hepatocellular carcinoma metastasis].
Cao MQ; Gao JR; Huang JF; You AB; Guo ZG; Zhou HY; Fang F; Zhang W; Zhu XL; Zhang T
Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):18-23. PubMed ID: 28104028
[No Abstract] [Full Text] [Related]
8. HIF-2-dependent expression of stem cell factor promotes metastasis in hepatocellular carcinoma.
Wang X; Dong J; Jia L; Zhao T; Lang M; Li Z; Lan C; Li X; Hao J; Wang H; Qin T; Huang C; Yang S; Yu M; Ren H
Cancer Lett; 2017 May; 393():113-124. PubMed ID: 28153790
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance and clinicopathological features of hypoxic inducible factor-2alpha expression in hepatocellular carcinoma.
Yao Q; Lv Y; Pan T; Liu Y; Ma J; Xu G
Saudi Med J; 2015 Feb; 36(2):170-5. PubMed ID: 25719580
[TBL] [Abstract][Full Text] [Related]
10. 2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2.
Ma L; Li G; Zhu H; Dong X; Zhao D; Jiang X; Li J; Qiao H; Ni S; Sun X
Cancer Lett; 2014 Dec; 355(1):96-105. PubMed ID: 25218350
[TBL] [Abstract][Full Text] [Related]
11. HIF-2α regulates CDCP1 to promote PKCδ-mediated migration in hepatocellular carcinoma.
Cao M; Gao J; Zhou H; Huang J; You A; Guo Z; Fang F; Zhang W; Song T; Zhang T
Tumour Biol; 2016 Feb; 37(2):1651-62. PubMed ID: 26307391
[TBL] [Abstract][Full Text] [Related]
12. Expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor in hepatocellular carcinoma: Impact on neovascularization and survival.
Huang GW; Yang LY; Lu WQ
World J Gastroenterol; 2005 Mar; 11(11):1705-8. PubMed ID: 15786555
[TBL] [Abstract][Full Text] [Related]
13. [Expression of hypoxia-inducible factor-1-alpha, hypoxia-inducible factor-2alpha and vascular endothelial growth factor in sporadic clear cell renal cell renal cell carcinoma and their significance in the pathogenesis thereof].
Zhang N; Gong K; Yang XY; Xin DQ; Na YQ
Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(22):1526-9. PubMed ID: 16854277
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells.
Zhao D; Zhai B; He C; Tan G; Jiang X; Pan S; Dong X; Wei Z; Ma L; Qiao H; Jiang H; Sun X
Cell Signal; 2014 May; 26(5):1030-9. PubMed ID: 24486412
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia inducible factor 1α in hepatocellular carcinoma with cirrhosis: Association with prognosis.
Wang D; Zhang X; Lu Y; Wang X; Zhu L
Pathol Res Pract; 2018 Dec; 214(12):1987-1992. PubMed ID: 30274686
[TBL] [Abstract][Full Text] [Related]
16. Regulation of vascular endothelial growth factor transcription by endothelial PAS domain protein 1 (EPAS1) and possible involvement of EPAS1 in the angiogenesis of renal cell carcinoma.
Xia G; Kageyama Y; Hayashi T; Kawakami S; Yoshida M; Kihara K
Cancer; 2001 Apr; 91(8):1429-36. PubMed ID: 11301389
[TBL] [Abstract][Full Text] [Related]
17. Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma.
Sivridis E; Giatromanolaki A; Gatter KC; Harris AL; Koukourakis MI;
Cancer; 2002 Sep; 95(5):1055-63. PubMed ID: 12209691
[TBL] [Abstract][Full Text] [Related]
18. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.
Hui EP; Chan AT; Pezzella F; Turley H; To KF; Poon TC; Zee B; Mo F; Teo PM; Huang DP; Gatter KC; Johnson PJ; Harris AL
Clin Cancer Res; 2002 Aug; 8(8):2595-604. PubMed ID: 12171890
[TBL] [Abstract][Full Text] [Related]
19. Downregulation and pro-apoptotic effect of hypoxia-inducible factor 2 alpha in hepatocellular carcinoma.
Yang SL; Liu LP; Niu L; Sun YF; Yang XR; Fan J; Ren JW; Chen GG; Lai PB
Oncotarget; 2016 Jun; 7(23):34571-81. PubMed ID: 27119229
[TBL] [Abstract][Full Text] [Related]
20. Downregulating hypoxia-inducible factor-2α improves the efficacy of doxorubicin in the treatment of hepatocellular carcinoma.
He C; Sun XP; Qiao H; Jiang X; Wang D; Jin X; Dong X; Wang J; Jiang H; Sun X
Cancer Sci; 2012 Mar; 103(3):528-34. PubMed ID: 22145922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
